Novel Diagnosis and Therapeutic Strategies for Gestational Diabetes
A special issue of Diabetology (ISSN 2673-4540).
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 3619
Special Issue Editor
Special Issue Information
Dear Colleagues,
As Guest Editor of this Special Issue of Diabetology titled "Novel Diagnosis and Therapeutic Strategies for Gestational Diabetes", I am inviting you to submit an original research article/review paper on the topic. Diabetology (ISSN 2673-4540) is an international open-access journal.
In this Special Issue of Diabetology, we invite researchers to submit their works focusing on novel biomarkers and/or therapeutic targets in gestational diabetes.
The official deadline for submitting papers is 15 April 2022, and the instructions on how to proceed with writing will be available on a dedicated web page. Research areas may include (but are not limited to) the following:
- Successful strategies to prevent GDM;
- Biomarkers and mechanisms that can predict pregnancy complications, and on the long-term metabolic risk;
- New therapeutic strategies on short- and long-term clinical outcomes of pregnancy complicated by gestational diabetes.
I look forward to receiving your contributions.
Dr. Rossella Liani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diabetology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gestational diabetes
- transcriptomics
- proteomics
- biomarkers
- therapeutic targets
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
